The U.S. Justice Department claims 33-year-old Andrew Fisher agreed to fill illegitimate prescriptions to boost revenue. In addition, Mr. Fisher allegedly paid a commission to marketing representatives who recruited patients to receive compounded drug prescriptions from his pharmacy.
Prosecutors also allege Mr. Fisher, who is not a licensed pharmacist, told his employees to use ingredients that would maximize the amount his pharmacy could bill to insurers.
He faces healthcare fraud, wire fraud and money-laundering charges.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
New Jersey physician, pharmacy workers charged in $10M kickback scheme
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.